Progress of Mesoporous Silica Coated Gold Nanorods for Biological Imaging and Cancer Therapy

被引:5
作者
Ma, Jiaying [1 ]
Li, Yongzhen [2 ]
Ying, Yunfei [1 ]
Wu, Baibei [3 ]
Liu, Yanmei [1 ]
Zhou, Juan [4 ]
Hu, Lidan [1 ]
机构
[1] Univ South China, Sch Basic Med, Dept Biochem & Mol Biol, Hengyang 421001, Peoples R China
[2] Univ South China, Sch Pharm, Dept Pharm, Hengyang 421001, Peoples R China
[3] Univ South China, Dept Clin Med, Hengyang 421001, Peoples R China
[4] Univ South China, Sch Mech Engn, Hengyang 421001, Peoples R China
关键词
nanomaterial; synthesis; biological imaging; tumor therapy; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; MULTIDRUG-RESISTANCE; BIOMEDICAL APPLICATIONS; COMBINED CHEMOTHERAPY; PHOTOTHERMAL THERAPY; DRUG-DELIVERY; NANOPARTICLES; FLUORESCENCE; NANOMEDICINE;
D O I
10.1002/cmdc.202300374
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For unique surface plasmon absorption and fluorescence characteristics, gold nanorods have been developed and widely employed in the biomedical field. However, limitations still exist due their low specific surface area, instability and tendency agglomerate in cytoplasm. Mesoporous silica materials have been broadly applied in field of catalysts, adsorbents, nanoreactors, and drug carriers due to its unique mesoporous structure, highly comparative surface area, good stability and biocompatibility. Therefore, coating gold nanorods with a dendritic mesopore channels can effectively prevent particle agglomeration, while increasing the specific surface area and drug loading efficiency. This review discusses the advancements of GNR@MSN in synthetic process, bio-imaging technique and tumor therapy. Additionally, the further application of GNR@MSN in imaging-guided treatment modalities is explored, while its promising superior application prospect is highlighted. Finally, the issues related to in vivo studies are critically examined for facilitating the transition of this promising nanoplatform into clinical trials. The coating of mesoporous silica nanoshells can improve the stability of gold nanorods while improving the corresponding drug-carrying capacity. Mesoporous silica coated gold nanorod (GNR@MSN) provides the opportunity to integrate different treatments into a single nanoplatform combining cancer treatment with real-time diagnosis. This review discusses the advancements of GNR@MSN in synthetic process, bio-imaging techniques and tumor therapy. image
引用
收藏
页数:10
相关论文
共 158 条
[1]   Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods [J].
Alchera, Elisa ;
Monieri, Matteo ;
Maturi, Mirko ;
Locatelli, Irene ;
Locatelli, Erica ;
Tortorella, Silvia ;
Sacchi, Angelina ;
Corti, Angelo ;
Nebuloni, Manuela ;
Luciano, Roberta ;
Pederzoli, Filippo ;
Montorsi, Francesco ;
Salonia, Andrea ;
Meyer, Sandra ;
Jose, Jithin ;
Giustetto, Pierangela ;
Franchini, Mauro Comes ;
Curnis, Flavio ;
Alfano, Massimo .
PHOTOACOUSTICS, 2022, 28
[2]   Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions [J].
Alkilany, Alaaldin M. ;
Thompson, Lucas B. ;
Boulos, Stefano P. ;
Sisco, Patrick N. ;
Murphy, Catherine J. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (02) :190-199
[3]   Cellular Uptake and Cytotoxicity of Gold Nanorods: Molecular Origin of Cytotoxicity and Surface Effects [J].
Alkilany, Alaaldin M. ;
Nagaria, Pratik K. ;
Hexel, Cole R. ;
Shaw, Timothy J. ;
Murphy, Catherine J. ;
Wyatt, Michael D. .
SMALL, 2009, 5 (06) :701-708
[4]   IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies [J].
Alves, Catia G. ;
Lima-Sousa, Rita ;
de Melo-Diogo, Duarte ;
Louro, Ricardo O. ;
Correia, Ilidio J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 542 (1-2) :164-175
[5]   Super-Resolution Photoacoustic Microscopy Using Structured-Illumination [J].
Amjadian, Mohammadreza ;
Mostafavi, Seyed Masood ;
Chen, Jiangbo ;
Kavehvash, Zahra ;
Zhu, Jingyi ;
Wang, Lidai .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2021, 40 (09) :2197-2207
[6]   The multi-factorial nature of clinical multidrug resistance in cancer [J].
Assaraf, Yehuda G. ;
Brozovic, Anamaria ;
Goncalves, Ana Cristina ;
Jurkovicova, Dana ;
Line, Aija ;
Machuqueiro, Miguel ;
Saponara, Simona ;
Sarmento-Ribeiro, Ana Bela ;
Xavier, Cristina P. R. ;
Vasconcelos, M. Helena .
DRUG RESISTANCE UPDATES, 2019, 46
[7]   Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer [J].
Baekelandt, M ;
Lehne, G ;
Tropé, CG ;
Szántó, I ;
Pfeiffer, P ;
Gustavssson, B ;
Kristensen, GB .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) :2983-2993
[8]   Photo-triggered polymer nanomedicines: From molecular mechanisms to therapeutic applications [J].
Beaute, Louis ;
McClenaghan, Nathan ;
Lecommandoux, Sebastien .
ADVANCED DRUG DELIVERY REVIEWS, 2019, 138 :148-166
[9]   In Vivo Tracking of the Degradation of Mesoporous Silica through 89Zr Radio-Labeled Core-Shell Nanoparticles [J].
Bindini, Elisa ;
de los Angeles Ramirez, Maria ;
Rios, Xabier ;
Cossio, Unai ;
Simo, Cristina ;
Gomez-Vallejo, Vanessa ;
Soler-Illia, Galo ;
Llop, Jordi ;
Moya, Sergio E. .
SMALL, 2021, 17 (30)
[10]   Better Therapeutic Trials in Ovarian Cancer [J].
Bookman, Michael A. ;
Gilks, C. Blake ;
Kohn, Elise C. ;
Kaplan, Karen O. ;
Huntsman, David ;
Aghajanian, Carol ;
Birrer, Michael J. ;
Ledermann, Jonathan A. ;
Oza, Amit M. ;
Swenerton, Kenneth D. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04)